3 Blockbuster Drugs That May Be Obsolete in 5 Years
Motley Fool experts highlight three blockbuster-selling therapies that could fall by the wayside in the next five years.
5 Key Findings After 1 Full Year of Obamacare
Express Scripts offers five key takeaways on drug spending tied to Obamacare exchange plans.
5 Things AbbVie Inc.'s Management Wants You to Know
How AbbVie is doing and what lies ahead -- straight from the company's executives.